✦ LIBER ✦

Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract

✍ Scribed by Kuniaki Nakanishi; Toshiaki Kawai; Sadayuki Hiroi; Fumiyuki Kumaki; Chikao Torikata; Takashi Aurues; Tomosumi Ikeda

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 281 KB
Volume: 86
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19991115)86:10<2109::aid-cncr32>3.0.co;2-6

No coin nor oath required. For personal study only.

✦ Synopsis

The authors are indebted to Geron Corporation, Menlo Park, CA, for the gift of a human telomerase RNA component (hTR) probe; Dr.

📜 SIMILAR VOLUMES

Recurrent urothelial tumors following su

Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract

✍ David W. Strong; Harper D. Pearse 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 1 views

A retrospective analysis of 74 cases of transitional cell carcinoma of the renal pelvis and ureter treated at this institution over the past 30 years is presented. When nephrectomy alone or incomplete nephroureterectomy was performed, subsequent transitional cell carcinoma developed in 30% of the ur

A phase II study of mitoguazone and vinb

A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract

✍ John T. Barrett; Bruno Orofiamma; Janardan D. Khandekar; Paul P. Carbone; Robert 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 1 views

This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0

A study of cyclophosphamide, adriamycin,

A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract

✍ Dennis L. Citrin; Tom F. Hogan; Tom E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twenty patients with locally advanced and/or metastatic transitional cell cancer of the urinary tract were treated with cyclophosphamide 500 mg/m2, Adriamycin (doxorubicin) 40 mg/m2 and cis-platinum (CDDP) 40 mg/m2 given every three weeks for 2 cycles, alternating with methotrexate 40 mg/m2 weekly f

Expression of class I histocompatibility

Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival

✍ I. Levin; T. Klein; J. Goldstein; O. Kuperman; J. Kanetti; B. Klein 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Microsatellite instability in transition

Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking

✍ Toyoaki Uchida; Chunxi Wang; Chieki Wada; Masatsugu Iwamura; Shin Egawa; Ken Kos 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 420 KB 👁 1 views

To determine whether microsatellite instability is involved in the development of transitional cell carcinoma (TCC) of the urinary tract, a microsatellite instability assay was carried out using PCR with 9 microsatellite loci. Thirty-eight TCC samples (30 patients with bladder cancer, 5 with renal p

Human mismatch repair gene (hMSH2) produ

Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder

✍ Tie-Xiong Jin; Mutsuo Furihata; Ichiro Yamasaki; Masayuki Kamada; Sheng-Ben Lian 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

## Background: Several convincing studies have shown that the hmsh2 gene plays major roles in mismatch repair by recognizing mismatched bases and preventing mutations during dna replication. loss of this function may result in the accumulation of dna replication errors or even the mutator phenotype